Last 12 months
Inside the activity.
2 purchase rows · 24 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 5 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 17, 2020 Filed Aug 18, 2020 19:03 UTC |
Sharpe Matthew P.Executive Vice President
|
Exercise / conversionCommon Stock | 7,464 | $31.01 | $231,458.64 |
DisclosureSEC source: 0001214659-20-007305 · marketforms-49483.xml · nonDerivative · entry 6 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,895.303 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · balance_after: Represents 50,082.303 vested restricted stock units and 30,813 shares of Common Stock. Read SEC document |
| August 17, 2020 Filed Aug 18, 2020 19:03 UTC |
Sharpe Matthew P.Executive Vice President
|
Exercise / conversionCommon Stock | 1,162 | $32.35 | $37,590.70 |
DisclosureSEC source: 0001214659-20-007305 · marketforms-49483.xml · nonDerivative · entry 5 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,431.303 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · balance_after: Represents 50,082.303 vested restricted stock units and 23,349 shares of Common Stock. Read SEC document |
| August 17, 2020 Filed Aug 18, 2020 19:03 UTC |
Sharpe Matthew P.Executive Vice President
|
Exercise / conversionCommon Stock | 1,682 | $28.88 | $48,576.16 |
DisclosureSEC source: 0001214659-20-007305 · marketforms-49483.xml · nonDerivative · entry 4 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,269.303 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · balance_after: Represents 50,082.303 vested restricted stock units and 22,187 shares of Common Stock. Read SEC document |
| August 14, 2020 Filed Aug 18, 2020 19:03 UTC |
Sharpe Matthew P.Executive Vice President
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 9,612 | $0.00 Strike: $31.01 | $0.00 |
DisclosureSEC source: 0001214659-20-007305 · marketforms-49483.xml · derivative · entry 9 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,360 Underlying: Common Stock · 9,612 shares Expires 2026-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2020 Filed Aug 18, 2020 19:03 UTC |
Sharpe Matthew P.Executive Vice President
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,018 | $0.00 Strike: $28.88 | $0.00 |
DisclosureSEC source: 0001214659-20-007305 · marketforms-49483.xml · derivative · entry 8 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,795 Underlying: Common Stock · 2,018 shares Expires 2024-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2020 Filed Aug 18, 2020 19:03 UTC |
Sharpe Matthew P.Executive Vice President
|
SaleCommon Stock | 9,612 | $39.63 | $380,920.68 |
DisclosureSEC source: 0001214659-20-007305 · marketforms-49483.xml · nonDerivative · entry 3 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,587.303 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.55 to $39.72. F1 · balance_after: Represents 50,082.303 vested restricted stock units and 20,505 shares of Common Stock. Read SEC document |
| August 14, 2020 Filed Aug 18, 2020 19:03 UTC |
Sharpe Matthew P.Executive Vice President
|
Exercise / conversionCommon Stock | 9,612 | $31.01 | $298,068.12 |
DisclosureSEC source: 0001214659-20-007305 · marketforms-49483.xml · nonDerivative · entry 2 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,199.303 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Represents 50,082.303 vested restricted stock units and 30,117 shares of Common Stock. Read SEC document |
| August 14, 2020 Filed Aug 18, 2020 19:03 UTC |
Sharpe Matthew P.Executive Vice President
|
Exercise / conversionCommon Stock | 2,018 | $28.88 | $58,279.84 |
DisclosureSEC source: 0001214659-20-007305 · marketforms-49483.xml · nonDerivative · entry 1 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,587.303 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Represents 50,082.303 vested restricted stock units and 20,505 shares of Common Stock. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 17:52 UTC |
ZURAITIS MARITADirector · President & CEO
|
SaleCommon Stock | 10,000 | $40.63 | $406,273.00 |
DisclosureSEC source: 0001214659-20-007035 · marketforms-49449.xml · nonDerivative · entry 1 ZURAITIS MARITA · CIK 0001198960 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,826.172 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $40.37 to $40.96. F2 · balance_after: Represents 176,664.172 vested restricted stock units and 70,162 shares of Common Stock. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:16 UTC |
Sharpe Matthew P.Executive Vice President
|
SaleCommon Stock | 3,500 | $40.42 | $141,456.00 |
DisclosureSEC source: 0001214659-20-005523 · marketforms-49023.xml · nonDerivative · entry 1 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,973.559 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on June 27, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.27 to $40.88. F3 · balance_after: Represents 49,676.559 vested restricted stock units and 18,297 shares of Common Stock. Please note the beneficial ownership amount reported has been corrected to reflect the sale of 10,061 shares on June 1, 2018. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 17:51 UTC |
McClure Beverley J.Director
|
SaleCommon Stock | 450 | $36.65 | $16,492.50 |
DisclosureSEC source: 0001214659-20-005321 · marketforms-48955.xml · nonDerivative · entry 1 McClure Beverley J. · CIK 0001577358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,720.672 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2019. F2 · balance_after: Represents 13,822.672 vested restricted stock units and 4,898 shares of Common Stock. Read SEC document |
| May 20, 2020 Filed May 22, 2020 18:16 UTC |
Hines Perry G.Director
|
GrantCommon Stock | 3,153 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-004942 · marketforms-48858.xml · nonDerivative · entry 1 Hines Perry G. · CIK 0001741555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,248.374 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in full on May 20, 2021. F2 · price: Granted as compensation for services. F3 · balance_after: Represents 2,248.374 vested share-based restricted stock units. Read SEC document |
| May 20, 2020 Filed May 22, 2020 18:22 UTC |
Reece Henry WadeDirector
|
GrantCommon Stock | 2,149.613 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-004945 · marketforms-48861.xml · nonDerivative · entry 2 Reece Henry Wade · CIK 0001675638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,416.428 F4 · security: The acquisition of Common Stock reported hereby is in the form of deferred cash restricted stock units pursuant to the 2010 Comprehensive Executive Compensation Plan as amended and restated. F2 · price: Granted as compensation for services. F5 · balance_after: Represents 8,119.868 vested share-based restricted stock units and 5,296.560 deferred cash restricted stock units. Read SEC document |
| May 20, 2020 Filed May 22, 2020 18:22 UTC |
Reece Henry WadeDirector
|
GrantCommon Stock | 3,153 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-004945 · marketforms-48861.xml · nonDerivative · entry 1 Reece Henry Wade · CIK 0001675638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,266.815 F1 · security: The acquisition of Common Stock reported hereby is in the form of share-based restricted stock units which will vest in full on May 20, 2021. F2 · price: Granted as compensation for services. F3 · balance_after: Represents 8,119.868 vested share-based restricted stock units and 3,146.947 deferred cash restricted stock units. Read SEC document |
| May 20, 2020 Filed May 22, 2020 18:14 UTC |
Domenech Daniel ADirector
|
GrantCommon Stock | 3,153 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-004941 · marketforms-48857.xml · nonDerivative · entry 1 Domenech Daniel A · CIK 0001642977 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,920.158 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in full on May 20, 2021. F2 · price: Granted as compensation for services. F3 · balance_after: Represents 11,003.410 vested share-based restricted stock units and 6,916.748 deferred cash restricted stock units. Read SEC document |
| May 20, 2020 Filed May 22, 2020 18:26 UTC |
Swyers Steven O.Director
|
GrantCommon Stock | 3,153 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-004947 · marketforms-48863.xml · nonDerivative · entry 1 Swyers Steven O. · CIK 0001608926 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,748.165 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in full on May 20, 2021. F2 · price: Granted as compensation for services. F3 · balance_after: Represents 14,748.165 vested share-based restricted stock units. Read SEC document |
| May 20, 2020 Filed May 22, 2020 18:23 UTC |
Stricker RobertDirector
|
GrantCommon Stock | 3,153 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-004946 · marketforms-48862.xml · nonDerivative · entry 1 Stricker Robert · CIK 0001478287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,859.152 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in full on May 20, 2021. F2 · price: Granted as compensation for services. F3 · balance_after: Represents 12,061.143 vested share-based restricted stock units, 10,831.009 deferred cash restricted stock units and 10,967 shares of Common Stock. Read SEC document |
| May 20, 2020 Filed May 22, 2020 18:18 UTC |
KONEN MARK EDirector
|
GrantCommon Stock | 3,153 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-004943 · marketforms-48859.xml · nonDerivative · entry 1 KONEN MARK E · CIK 0001280429 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in full on May 20, 2021. F2 · price: Granted as compensation for services. Read SEC document |
| May 20, 2020 Filed May 22, 2020 18:20 UTC |
McClure Beverley J.Director
|
GrantCommon Stock | 3,153 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-004944 · marketforms-48860.xml · nonDerivative · entry 1 McClure Beverley J. · CIK 0001577358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,401.13 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in full on May 20, 2021. F2 · price: Granted as compensation for services. F3 · balance_after: Represents 11,053.130 vested restricted stock units and 5,348 shares of Common Stock. Read SEC document |
| May 20, 2020 Filed May 22, 2020 18:11 UTC |
Casady Mark SDirector
|
GrantCommon Stock | 3,153 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-004939 · marketforms-48856.xml · nonDerivative · entry 1 Casady Mark S · CIK 0001405275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in full on May 20, 2021. F2 · price: Granted as compensation for services. Read SEC document |
| May 08, 2020 Filed May 12, 2020 18:07 UTC |
Sharpe Matthew P.Executive Vice President
|
SaleCommon Stock | 3,500 | $35.00 | $122,500.00 |
DisclosureSEC source: 0001214659-20-004381 · marketforms-48779.xml · nonDerivative · entry 1 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,534.559 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on June 27, 2019. F2 · balance_after: Represents 49,676.559 vested restricted stock units and 31,858 shares of Common Stock. Read SEC document |
| April 09, 2020 Filed Apr 13, 2020 19:25 UTC |
Sharpe Matthew P.Executive Vice President
|
SaleCommon Stock | 3,500 | $35.00 | $122,500.00 |
DisclosureSEC source: 0001214659-20-003319 · marketforms-48562.xml · nonDerivative · entry 1 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,025.35 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on June 27, 2019. F2 · balance_after: Represents 49,667.350 vested restricted stock units and 35,358 shares of Common Stock. Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 18:33 UTC |
McClure Beverley J.Director
|
SaleCommon Stock | 450 | $34.00 | $15,300.00 |
DisclosureSEC source: 0001214659-20-003077 · marketforms-48469.xml · nonDerivative · entry 1 McClure Beverley J. · CIK 0001577358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,311.243 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2019. F2 · balance_after: Represents 10,963.243 vested restricted stock units and 5,348 shares of Common Stock. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 21:22 UTC |
ZURAITIS MARITADirector · President & CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 9,248 | $0.00 Strike: $22.69 | $0.00 |
DisclosureSEC source: 0001214659-20-002665 · marketforms-48333.xml · derivative · entry 2 ZURAITIS MARITA · CIK 0001198960 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,248 shares Expires 2020-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 21:22 UTC |
ZURAITIS MARITADirector · President & CEO
|
Exercise / conversionCommon Stock | 9,248 | $22.69 | $209,837.12 |
DisclosureSEC source: 0001214659-20-002665 · marketforms-48333.xml · nonDerivative · entry 1 ZURAITIS MARITA · CIK 0001198960 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,268.637 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Represents 174,511.637 vested restricted stock units and 87,757 shares of Common Stock. Read SEC document |
| March 06, 2020 Filed Mar 10, 2020 19:20 UTC |
Sharpe Matthew P.Executive Vice President
|
SaleCommon Stock | 3,500 | $40.24 | $140,836.85 |
DisclosureSEC source: 0001214659-20-002463 · marketforms-48287.xml · nonDerivative · entry 1 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,473.786 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on June 27, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.63 to $40.89. F3 · balance_after: Represents 58,749.786 vested restricted stock units and 31,724 shares of Common Stock. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 23:34 UTC |
Carley Donald MGeneral Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 17,444 | $0.00 Strike: $41.83 | $0.00 |
DisclosureSEC source: 0001214659-20-002367 · marketforms-48212.xml · derivative · entry 3 Carley Donald M · CIK 0001665149 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,444 shares Expires 2030-03-04 F5 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 4, 2021. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 23:34 UTC |
Carley Donald MGeneral Counsel
|
GrantCommon Stock | 3,705.81 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-002367 · marketforms-48212.xml · nonDerivative · entry 2 Carley Donald M · CIK 0001665149 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,882.281 F3 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which are fully vested. F4 · balance_after: Represents 9,634.281 vested restricted stock units and 3,248 shares of Common Stock. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 23:34 UTC |
Carley Donald MGeneral Counsel
|
GrantCommon Stock | 1,674 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-002367 · marketforms-48212.xml · nonDerivative · entry 1 Carley Donald M · CIK 0001665149 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,176.471 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 4, 2021. F2 · balance_after: Represents 5,928.471 vested restricted stock units and 3,248 shares of Common Stock. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 23:35 UTC |
Moore Elizabeth PChief Human Resources Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 7,476 | $0.00 Strike: $41.83 | $0.00 |
DisclosureSEC source: 0001214659-20-002370 · marketforms-48219.xml · derivative · entry 3 Moore Elizabeth P · CIK 0001758380 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,476 shares Expires 2030-03-04 F5 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 4, 2021. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 23:35 UTC |
Moore Elizabeth PChief Human Resources Officer
|
GrantCommon Stock | 1,365.812 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-002370 · marketforms-48219.xml · nonDerivative · entry 2 Moore Elizabeth P · CIK 0001758380 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,746.174 F3 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which are fully vested. F4 · balance_after: Represents 1,380.174 vested restricted stock units and 2,366 shares of Common Stock. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 23:35 UTC |
Moore Elizabeth PChief Human Resources Officer
|
GrantCommon Stock | 720 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-002370 · marketforms-48219.xml · nonDerivative · entry 1 Moore Elizabeth P · CIK 0001758380 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,380.362 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 4, 2021. F2 · balance_after: Represents 14.362 vested restricted stock units and 2,366 shares of Common Stock. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 23:35 UTC |
JOHNSON KIMBERLY ASVP & Controller
|
GrantCommon Stock | 975.274 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-002369 · marketforms-48217.xml · nonDerivative · entry 2 JOHNSON KIMBERLY A · CIK 0001708307 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,846.189 F3 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which are fully vested. F4 · balance_after: Represents 17,207.351 vested restricted stock units and 3,638.838 shares of Common Stock. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 23:35 UTC |
JOHNSON KIMBERLY ASVP & Controller
|
GrantCommon Stock | 1,497 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-002369 · marketforms-48217.xml · nonDerivative · entry 1 JOHNSON KIMBERLY A · CIK 0001708307 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,870.915 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 4, 2021. F2 · balance_after: Represents 16,232.077 vested restricted stock units and 3,638.838 shares of Common Stock. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 23:35 UTC |
CONKLIN BRET AEVP & CFO
|
GrantEmployee Stock Option (right to buy) · Derivative | 27,412 | $0.00 Strike: $41.83 | $0.00 |
DisclosureSEC source: 0001214659-20-002368 · marketforms-48214.xml · derivative · entry 4 CONKLIN BRET A · CIK 0001247242 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,412 shares Expires 2030-03-04 F5 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 4, 2021. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 23:35 UTC |
CONKLIN BRET AEVP & CFO
|
GrantCommon Stock | 3,641.454 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-002368 · marketforms-48214.xml · nonDerivative · entry 2 CONKLIN BRET A · CIK 0001247242 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,208.746 F3 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which are fully vested. F4 · balance_after: Represents 34,145.566 vested share-based restricted stock units, 9,615.386 deferred cash restricted stock units and 6,447.794 shares of Common Stock. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 23:35 UTC |
CONKLIN BRET AEVP & CFO
|
GrantCommon Stock | 2,631 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-002368 · marketforms-48214.xml · nonDerivative · entry 1 CONKLIN BRET A · CIK 0001247242 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,567.292 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 4, 2021. F2 · balance_after: Represents 30,504.112 vested share-based restricted stock units, 9,615.386 deferred cash restricted stock units and 6,447.794 shares of Common Stock. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 23:33 UTC |
ZURAITIS MARITADirector · President & CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 109,648 | $0.00 Strike: $41.83 | $0.00 |
DisclosureSEC source: 0001214659-20-002365 · marketforms-48223.xml · derivative · entry 3 ZURAITIS MARITA · CIK 0001198960 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 109,648 shares Expires 2030-03-04 F5 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 4, 2021. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 23:33 UTC |
ZURAITIS MARITADirector · President & CEO
|
GrantCommon Stock | 20,154.502 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-002365 · marketforms-48223.xml · nonDerivative · entry 2 ZURAITIS MARITA · CIK 0001198960 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,958.731 F3 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which are fully vested. F4 · balance_after: Represents 194,672.731 vested restricted stock units and 62,286 shares of Common Stock. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 23:33 UTC |
ZURAITIS MARITADirector · President & CEO
|
GrantCommon Stock | 10,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-002365 · marketforms-48223.xml · nonDerivative · entry 1 ZURAITIS MARITA · CIK 0001198960 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,804.229 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 4, 2021. F2 · balance_after: Represents 174,518.229 vested restricted stock units and 62,286 shares of Common Stock. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 23:34 UTC |
Caldwell William J.Executive Vice President
|
GrantEmployee Stock Option (right to buy) · Derivative | 22,428 | $0.00 Strike: $41.83 | $0.00 |
DisclosureSEC source: 0001214659-20-002366 · marketforms-48209.xml · derivative · entry 3 Caldwell William J. · CIK 0001624521 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,428 shares Expires 2030-03-04 F5 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 4, 2021. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 23:34 UTC |
Caldwell William J.Executive Vice President
|
GrantCommon Stock | 4,681.08 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-002366 · marketforms-48209.xml · nonDerivative · entry 2 Caldwell William J. · CIK 0001624521 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,506.094 F3 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which are fully vested. F4 · balance_after: Represents 6,097.094 vested restricted stock units and 38,409 shares of Common Stock. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 23:34 UTC |
Caldwell William J.Executive Vice President
|
GrantCommon Stock | 2,154 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-002366 · marketforms-48209.xml · nonDerivative · entry 1 Caldwell William J. · CIK 0001624521 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,825.014 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 4, 2021. F2 · balance_after: Represents 1,416.014 vested restricted stock units and 38,409 shares of Common Stock. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 23:33 UTC |
Sharpe Matthew P.Executive Vice President
|
GrantEmployee Stock Option (right to buy) · Derivative | 27,412 | $0.00 Strike: $41.83 | $0.00 |
DisclosureSEC source: 0001214659-20-002364 · marketforms-48221.xml · derivative · entry 3 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,412 shares Expires 2030-03-04 F5 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 4, 2021. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 23:33 UTC |
Sharpe Matthew P.Executive Vice President
|
GrantCommon Stock | 7,347.255 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-002364 · marketforms-48221.xml · nonDerivative · entry 2 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,105.652 F3 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which are fully vested. F4 · balance_after: Represents 56,881.652 vested restricted stock units and 35,224 shares of Common Stock. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 23:33 UTC |
Sharpe Matthew P.Executive Vice President
|
GrantCommon Stock | 2,631 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-002364 · marketforms-48221.xml · nonDerivative · entry 1 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,758.397 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 4, 2021. F2 · balance_after: Represents 49,534.397 vested restricted stock units and 35,224 shares of Common Stock. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 23:28 UTC |
Rugenstein WadeExecutive Vice President
|
GrantEmployee Stock Option (right to buy) · Derivative | 22,428 | $0.00 Strike: $41.83 | $0.00 |
DisclosureSEC source: 0001214659-20-002363 · marketforms-48220.xml · derivative · entry 2 Rugenstein Wade · CIK 0001782331 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,428 shares Expires 2030-03-04 F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 4, 2021. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 23:28 UTC |
Rugenstein WadeExecutive Vice President
|
GrantCommon Stock | 2,154 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-002363 · marketforms-48220.xml · nonDerivative · entry 1 Rugenstein Wade · CIK 0001782331 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 4, 2021. Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 17:31 UTC |
JOHNSON KIMBERLY ASVP & Controller
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 463 | $0.00 Strike: $20.60 | $0.00 |
DisclosureSEC source: 0001214659-20-002275 · marketforms-48148.xml · derivative · entry 3 JOHNSON KIMBERLY A · CIK 0001708307 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 463 shares Expires 2020-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 17:31 UTC |
JOHNSON KIMBERLY ASVP & Controller
|
SaleCommon Stock | 241 | $40.01 | $9,641.37 |
DisclosureSEC source: 0001214659-20-002275 · marketforms-48148.xml · nonDerivative · entry 2 JOHNSON KIMBERLY A · CIK 0001708307 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,836.768 F2 · balance_after: Represents 17,202.498 vested restricted stock units and 3,634.270 shares of Common Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.